Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer With Central Nervous System Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01913067
What this trial is testing

Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC

Who this might be right for
Brain MetastasisBreast CancerNon Small Cell Lung Cancer
Jules Bordet Institute
Testing effectiveness (Phase 2)UnknownNCT03356600
What this trial is testing

Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer

Who this might be right for
Brain Metastases
Shanxi Province Cancer Hospital 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT02696993
What this trial is testing

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)UnknownNCT04193007
What this trial is testing

The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Second Affiliated Hospital of Nanchang University 100
Testing effectiveness (Phase 2)Ended earlyNCT04610684
What this trial is testing

Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases

Who this might be right for
Small-cell Lung CancerBrain Metastases
Jeffrey Clarke 3
Testing effectiveness (Phase 2)UnknownNCT01763385
What this trial is testing

Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases

Who this might be right for
Non-small-cell Lung CancerBrain Metastases
Wu Jieping Medical Foundation 210
Large-scale testing (Phase 3)Active Not RecruitingNCT04603807
What this trial is testing

Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 217
Testing effectiveness (Phase 2)Ended earlyNCT05746481
What this trial is testing

Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
Liza Villaruz, MD 3
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Not applicableLooking for participantsNCT07175077
What this trial is testing

7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)

Who this might be right for
Small-cell Lung CancerBrain Metastases
University of Missouri-Columbia 20
Early research (Phase 1)Ended earlyNCT00892801
What this trial is testing

Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Vanderbilt-Ingram Cancer Center 5
Very early researchEnded earlyNCT00253461
What this trial is testing

11C Topotecan PET Imaging

Who this might be right for
Lung CancerMetastatic CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT04965090
What this trial is testing

Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Metastatic Non Small Cell Lung CancerRecurrent Non Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 43
Early research (Phase 1)Study completedNCT01967095
What this trial is testing

Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer

Who this might be right for
EGFR-Mutant Lung Cancer
Memorial Sloan Kettering Cancer Center 53
Testing effectiveness (Phase 2)UnknownNCT05812534
What this trial is testing

Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Second Affiliated Hospital of Nanchang University 36
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04516070
What this trial is testing

Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis

Who this might be right for
Metastatic Lung Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Early research (Phase 1)Study completedNCT02228369
What this trial is testing

Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer

Who this might be right for
EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
AstraZeneca 108
Testing effectiveness (Phase 2)Study completedNCT06289023
What this trial is testing

HA-WBRT-SIB for Brain Metastasis of Lung Cancer

Who this might be right for
Lung NeoplasmBrain MetastasesSimultaneous Integrated Boost+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Next Page